---
title: Protheragen vs Southern Research
slug_a: obesityscientific
slug_b: southernresearch
site: cro
review_signal_gate: closed
canonical_path: /compare/obesityscientific/southernresearch
---

# Protheragen vs Southern Research

Side-by-side profile data from each company listing on this directory.

## Protheragen

- Profile: [/companies/obesityscientific](/companies/obesityscientific)

Protheragen — Specialized preclinical CRO dedicated to obesity research, offering comprehensive animal models, pharmacokinetic/pharmacodynamic studies, bioanalysis, and safety assessment for anti-obesity drug development.

Services: 27. Modalities: 5. Indications: 1. Locations: 0. Certifications: 0. The strongest documented coverage currently appears in services (27).

### Services

- Discovery Research
- Target Identification & Validation
- Medicinal Chemistry
- Preclinical In Vitro Studies
- In Vitro Pharmacology
- In Vitro ADME / DMPK
- Safety Pharmacology
- Preclinical In Vivo Studies
- In Vivo Efficacy Models
- In Vivo PK / PD Studies
- GLP Toxicology
- Specialized & Large-Animal Models
- Bioanalysis
- LC-MS Bioanalysis (Small Molecule)
- Ligand-Binding Bioanalysis (Large Molecule)
- Clinical Trial Services
- Phase I Clinical Trials
- Phase II Clinical Trials
- Phase III Clinical Trials
- Phase IV / Post-Marketing
- Clinical Operations
- Data Management & eClinical
- Biostatistics & Statistical Programming
- Pharmacovigilance & Drug Safety
- Medical Writing
- Regulatory Affairs
- US FDA Regulatory Strategy

### Modalities

- Small Molecule
- Biologics (Monoclonal Antibodies)
- Cell Therapy
- Gene Therapy
- Peptide

### Indications

- Metabolic

### Phases

- Preclinical (General)
- Phase I
- Discovery
- Phase II
- Phase III
- Phase IV

### Sourcing models

- Full-Service Outsourcing (FSO)

## Southern Research

- Profile: [/companies/southernresearch](/companies/southernresearch)

Southern Research — Leading contract research organization offering preclinical and clinical research services across infectious disease, oncology, and rare diseases, with specialized capabilities in bioanalytical labs, BSL-3 facilities, and in vivo models.

Services: 13. Modalities: 0. Indications: 3. Locations: 1. Certifications: 0. The strongest documented coverage currently appears in services (13).

### Services

- Discovery Research
- High-Throughput Screening
- Medicinal Chemistry
- In Vitro ADME / DMPK
- Safety Pharmacology
- Preclinical In Vivo Studies
- In Vivo Efficacy Models
- In Vivo PK / PD Studies
- GLP Toxicology
- Specialized & Large-Animal Models
- Bioanalysis
- Clinical Trial Services
- Pathology & Histology Services

### Modalities

- Data not yet provided.

### Indications

- Oncology
- Infectious Disease
- Rare Disease

### Phases

- Discovery
- Preclinical (General)

### Sourcing models

- Full-Service Outsourcing (FSO)